1233250-12-8

Basic information

• Product Name: N-[2-(4-chlorophenyl)ethyl]-4-[[4-(cyanomethyl)isoquinolin-1-yl]methyl]benzamide
• Synonyms: N-[2-(4-chlorophenyl)ethyl]-4-[[4-(cyanomethyl)isoquinolin-1-yl]methyl]benzamide
• CAS NO: 1233250-12-8
• Molecular Weight: 439.944
• Mol File: 1233250-12-8.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: N-[2-(4-chlorophenyl)ethyl]-4-[[4-(cyanomethyl)isoquinolin-1-yl]methyl]benzamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-[2-(4-chlorophenyl)ethyl]-4-[[4-(cyanomethyl)isoquinolin-1-yl]methyl]benzamide(1233250-12-8)
• EPA Substance Registry System: N-[2-(4-chlorophenyl)ethyl]-4-[[4-(cyanomethyl)isoquinolin-1-yl]methyl]benzamide(1233250-12-8)

Safety Data

• Hazardous Substances Data: 1233250-12-8(Hazardous Substances Data)

Upstream product

• 1233249-92-7 tert-butyl 4-[[4-(2-methoxy-2-oxoethyl)isoquinolin-1-yl]methyl]benzoate 
• 1233249-29-0 4-[[4-(2-amino-2-oxoethyl)isoquinolin-1-yl]methyl]-N-[2-(4-chlorophenyl)ethyl]benzamide 
• 1233249-94-9 methyl 2-[1-[[4-[2-(4-chlorophenyl)ethylcarbamoyl]phenyl]methyl]isoquinolin-4-yl]acetate 
• 1233249-93-8 4-[[4-(2-methoxy-2-oxoethyl)isoquinolin-1-yl]methyl]benzoic acid 
• 1233249-91-6 1-[[4-[(2-methylpropan-2-yl)oxycarbonyl]phenyl]methyl]isoquinoline-4-carboxylic acid 
• 1233249-90-5 methyl 1-[[4-[(2-methylpropan-2-yl)oxycarbonyl]phenyl]methyl]isoquinoline-4-carboxylate 
• 1233249-89-2 tributyl-[[4-[(2-methylpropan-2-yl)oxycarbonyl]phenyl]methyl]phosphanium bromide 
• 1233248-29-7 2-[1-[[4-[2-(4-chlorophenyl)ethylcarbamoyl]phenyl]methyl]isoquinolin-4-yl]acetic acid 
• 108052-76-2 4-(bromomethyl)benzoic acid 1,1-dimethylethyl ester 

Downstream Products

• 1660146-58-6 C₂₇H₂₃ClN₆O*C₆H₁₅N 

Relevant articles and documents

Isoquinoline derivatives as potent, selective, and orally active CRTH2 antagonists

Synthesis and structure-activity relationship of a novel series of isoquinoline CRTH2 antagonists bearing a methylene linker between the isoquinoline and benzamide moieties were described. Optimization focusing on the substituents of the benzamide portion in the right hand part of the molecule led to the identification of TASP0412098 (9l), which is a potent, selective CRTH2 antagonist (binding affinity: IC50=2.1 nM, functional activity: IC50=12 nM). Compound 9l, which was orally bioavailable in mice and guinea pigs, showed in vivo efficacy after oral administration in a bronchial asthma model of guinea pigs.